261 related articles for article (PubMed ID: 18240208)
1. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis.
Belostocki K; Pricop L; Redecha PB; Aydin A; Leff L; Harrison MJ; Salmon JE
Arthritis Rheum; 2008 Feb; 58(2):384-8. PubMed ID: 18240208
[TBL] [Abstract][Full Text] [Related]
2. A shift in the balance of inhibitory and activating Fcgamma receptors on monocytes toward the inhibitory Fcgamma receptor IIb is associated with prevention of monocyte activation in rheumatoid arthritis.
Wijngaarden S; van de Winkel JG; Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2004 Dec; 50(12):3878-87. PubMed ID: 15593228
[TBL] [Abstract][Full Text] [Related]
3. FcgammaRIIa is a target for modulation by TNFalpha in human neutrophils.
Belostocki K; Park MS; Redecha PB; Masuda E; Salmon JE; Pricop L
Clin Immunol; 2005 Oct; 117(1):78-86. PubMed ID: 16084773
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment.
Wijngaarden S; van Roon JA; van de Winkel JG; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2005 Jun; 44(6):729-34. PubMed ID: 15757966
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
6. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
7. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen.
Clavel C; Nogueira L; Laurent L; Iobagiu C; Vincent C; Sebbag M; Serre G
Arthritis Rheum; 2008 Mar; 58(3):678-88. PubMed ID: 18311806
[TBL] [Abstract][Full Text] [Related]
8. Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.
Garfield BE; Krahl T; Appel S; Cooper SM; Rincón M
Clin Immunol; 2005 Aug; 116(2):101-7. PubMed ID: 15914087
[TBL] [Abstract][Full Text] [Related]
9. Different amplifying mechanisms of interleukin-17 and interferon-gamma in Fcgamma receptor-mediated cartilage destruction in murine immune complex-mediated arthritis.
Grevers LC; van Lent PL; Koenders MI; Walgreen B; Sloetjes AW; Nimmerjahn F; Sjef Verbeek J; van den Berg WB
Arthritis Rheum; 2009 Feb; 60(2):396-407. PubMed ID: 19180490
[TBL] [Abstract][Full Text] [Related]
10. Increased FcgammaRII expression and aberrant tumour necrosis factor alpha production by mature dendritic cells from patients with active rheumatoid arthritis.
Radstake TR; Blom AB; Slöetjes AW; van Gorselen EO; Pesman GJ; Engelen L; Torensma R; van den Berg WB; Figdor CG; van Lent PL; Adema GJ; Barrera P
Ann Rheum Dis; 2004 Dec; 63(12):1556-63. PubMed ID: 15547078
[TBL] [Abstract][Full Text] [Related]
11. Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients.
Balanescu A; Radu E; Nat R; Regalia T; Bojinca V; Ionescu R; Balanescu S; Savu C; Predeteanu D
Int J Clin Pharmacol Res; 2005; 25(1):9-18. PubMed ID: 15864873
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
[TBL] [Abstract][Full Text] [Related]
13. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
14. The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis.
Matsumoto T; Kaneko T; Seto M; Wada H; Kobayashi T; Nakatani K; Tonomura H; Tono Y; Ohyabu M; Nobori T; Shiku H; Sudo A; Uchida A; Kurosawa DJ; Kurosawa S
Clin Appl Thromb Hemost; 2008 Apr; 14(2):186-92. PubMed ID: 18372277
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue.
Smeets TJ; Kraan MC; van Loon ME; Tak PP
Arthritis Rheum; 2003 Aug; 48(8):2155-62. PubMed ID: 12905468
[TBL] [Abstract][Full Text] [Related]
16. Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes.
Wijngaarden S; van de Winkel JG; Bijlsma JW; Lafeber FP; van Roon JA
Clin Exp Rheumatol; 2008; 26(1):89-95. PubMed ID: 18328152
[TBL] [Abstract][Full Text] [Related]
17. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
18. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis.
Magnusson SE; Engström M; Jacob U; Ulfgren AK; Kleinau S
Arthritis Res Ther; 2007; 9(3):R51. PubMed ID: 17521421
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis.
Abrahams VM; Cambridge G; Lydyard PM; Edwards JC
Arthritis Rheum; 2000 Mar; 43(3):608-16. PubMed ID: 10728755
[TBL] [Abstract][Full Text] [Related]
20. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
Sugihara M; Tsutsumi A; Suzuki E; Wakamatsu E; Suzuki T; Ogishima H; Hayashi T; Chino Y; Ishii W; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
Arthritis Rheum; 2007 Jul; 56(7):2160-9. PubMed ID: 17599736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
